| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |